Corcept: Use of Charitable Foundations Could Draw DOJ Scrutiny
Corcept Therapeutics Incorporated (CORT) appears to have provided patients with free Korlym or financial assistance through charitable foundations to give them access to the company’s expensive flagship drug. After those people got access to the drug, the company aggressively pushed them to enroll in a commercial or government health plan that would pay for future […]